Singapore, March 20 -- Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has announced the signing of five new distribution partners to expand its global presence.

The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies.

The newly signed distribution partners includeGeneWorks- Australia and New Zealand;Genomax- Singapore;PhileKorea- South Korea;Scrum Inc.- Japan; andSpinco- India

Alamar's technology empowers scientists to achieve groundbreaking insights in biomarker discovery, drug development, and disease research. Through these new partnerships, researchers in Asia-Pacific (A...